Exco Technologies Limited - Results for Third Quarter Ended June 30, 2014 Canada NewsWire
TORONTO , July 23, 2014 /CNW/ - Exco Technologies Limited (TSX-XTC) today announced results for its third quarter ended June 30, 2014 .
Sales up 78% Earnings up 50% $29 million cash on hand $1.1 million cash, net of bank indebtedness EBITDA up 27% to $14.9 million TORONTO , July 23, 2014 /PRNewswire/ - Exco Technologies Limited (TSX-XTC) today announced results for its third quarter ended June 30, 2014 .
Enanta Pharmaceuticals, Inc., (NASDAQ:ENTA), a research and
development-focused biotechnology company dedicated to creating small
molecule drugs in the infectious disease field, today reported financial
results for its fiscal third quarter ended June 30, 2014.
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION
NORTH CHICAGO, Ill.
Sign-up for Revised GAAP earnings guidance for AbbVie Inc for the Financial Year ending December 31, 2014 and Third Quarter ending September 30, 2014; Confirms Adjusted Earnings Guidance investment picks
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.